HeartStart FRx Defibrillator Event Registry

Launched by PHILIPS CLINICAL & MEDICAL AFFAIRS GLOBAL · Jan 30, 2020

Keywords

ClinConnect Summary

The HeartStart FRx Defibrillator Event Registry is a study designed to gather information about how well the HeartStart FRx Automated External Defibrillator (AED) works in real-life situations, specifically for people who experience sudden cardiac arrest. In this registry, researchers will collect data from patients who had the defibrillator pads applied, regardless of whether a shock was actually delivered. The goal is to ensure the device is safe and performs as expected when used according to the manufacturer's instructions. This study is observational, meaning participants are not given the device as part of a treatment plan; instead, their experiences are documented to help improve future use of the AED.

To be eligible for this study, participants must have been suspected of experiencing a circulatory arrest and had the HeartStart FRx AED with the proper pads applied. Importantly, the registry only includes those who had the device used on them in an emergency and not for practice. This study is currently recruiting participants of all ages and genders. If you are eligible and decide to participate, you can expect to contribute to important research that could enhance the safety and effectiveness of this life-saving device for others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subjects accepted into the study must: have been suspected of a circulatory arrest for any cause
• • Have had HeartStart FRx AED with electrodes: HeartStart SMART PADS II applied to their body and powered up, regardless of whether a defibrillation shock was delivered
• Exclusion Criteria:
• • AED or pad use other than the HeartStart FRx AED with electrodes : HeartStart SMART PADS II
• • AED used for training purposes.